Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS)
Zaki Al‐Yafeai, Manush Sondhi, Kavya Vadlamudi, Rahul Vyas, Daniyal M. Nadeem, Mohammed Alawadi, Alexander Carvajal-González, Mohamed Ghoweba, Anil Ananthaneni
Topics & Concepts
MedicineAdverse Event Reporting SystemAdverse effectPsoriasisAtrial fibrillationPericarditisInternal medicineCoronary artery diseaseSecukinumabPharmacovigilanceCardiologyDermatologyPsoriatic arthritisPsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and Therapies